# FDA Warning Letter: QuVa Pharma, Inc.
> 2024-02-13 · Division of Pharmaceutical Quality Operations I · `a0eb177db2fec7c7`
## Letter
- **Company:** QuVa Pharma, Inc.
- **Posted Date:** 2024-02-13
- **Letter Issue Date:** 2024-01-26
- **Issuing Office:** Division of Pharmaceutical Quality Operations I
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*